홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /화합물

Fentanyl Citrate

HCID 13810
새 노트새 반응견적 요청하기
인쇄 미리보기

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
990-73-8
표준 SMILES
CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O
InChIKey
IVLVTNPOHDFFCJ-UHFFFAOYSA-N
분자식
C28H36N2O8
평균 분자량
528.6 g/mol
단동위원소 질량
528.24716611

개요

Fentanyl citrate is the citric acid salt of fentanyl, comprising equimolar amounts of citric acid and fentanyl. A -opioid receptor agonist, it is a potent opioid analgesic used in the management of labour pain, postoperative pain, and chronic intractable cancer pain. It is also widely used as the analgesic component of balanced anaesthesia. It has a role as an opioid analgesic and a mu-opioid receptor agonist. It contains a fentanyl.

이름 및 식별자

우선 이름
Fentanyl Citrate
IUPAC
2-hydroxypropane-1,2,3-tricarboxylic acid;N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide

이름 및 동의어

FENTANYL CITRATE990-73-8LeptanalOraletPhentanyl citrateActiqAbstralLazandaOnsolisInstanylFentanyl buccalMcN-JR-4263-49
이름 더 보기
Fentanyl citrate ciiSUBLIMAZE PRESERVATIVE FREEMUN5LYG46HN-(1-Phenethyl-4-piperidyl)propionanilide citrateFENTANYL CITRATE PRESERVATIVE FREEKw-2246N-(1-Phenethyl-4-piperidyl)propionanilide dihydrogen citrateN-(1-Phenethyl-4-piperidinyl)propionanilide dihydrogen citrate

데이터베이스 식별자

CAS
990-73-8
PubChem CID
13810
DTXSID
DTXSID80243933
ChEMBL
CHEMBL688
ChEBI
CHEBI:31602
UNII
MUN5LYG46H
EC Number
213-588-0

물성

구조 계산 물성보충 중

극성 표면적
156 Ų
수소 결합 공여자 수
4
수소 결합 수용자 수
9
회전 가능 결합 수
11
무거운 원자 수
38
형식 전하
0
복잡도
618

실험 및 물리화학적 성질

Chemical ClassesOther Uses -> Pharmaceuticals
Human Drugs · 3건

FDA approved drugs -> Active ingredient

EMA approved medicines: Human medicine

FDA approved drugs -> Active ingredient

Animal DrugsActive Ingredients (Fentanyl Citrate) -> FDA Greenbook

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]

P233, P260, P261, P262, P264, P270, P271, P272, P280, P284, P301+P316, P302+P352, P304+P340, P316, P320, P321, P330, P333+P317, P342+P316, P361+P364, P362+P364, P403, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 68 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Regulatory InformationFentanyl citrate: HSNO Approval: HSR003800 Approved with controls
Other Safety InformationIMAP assessments - Propanamide, N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-,2-hydroxy-1,2,3-propanetricarboxylate (1:1): Environment tier I assessment
Hazards Summary · 1건

Fentanyl is a solid. It is a Schedule II controlled substance. Fentanyl citrate is a strong analgesic used preoperatively, during surgery, and in the immediate postoperative period for its analgesic action. . . . Introduced into clinical practice in the 1960s, the analgesic fentanyl is 100 times more potent than morphine. [HSDB] TLV Basis is CNS impairment and respiratory depression; [ACGIH TLVs and BEIs]

Hazard Classes and CategoriesAcute Tox. 2 (100%)

안전 및 보호

Threshold Limit Values (TLV) · 2건

0.00001, inhalable particulate matter (Surface Level = 1 ug/100cm2)

0.00002, inhalable particulate matter

독성 정보

화학 및 산업

약리 정보

FDA Pharmacological Classification · 2건

FENTANYL CITRATE

Opioid Agonist [EPC]; Full Opioid Agonists [MoA]

MeSH Pharmacological Classification · 4건

Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS.

Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage.

Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS.

Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174)

용도 및 제조

Use ClassificationAnimal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients

관련 반응

5건
반응 기록 만들기
HRID 8554 반응식
HRID 8554반응물로uspto-grants-2006_08
HRID 68194 반응식
HRID 68194반응물로uspto-grants-2014_09
HRID 68195 반응식
HRID 68195반응물로uspto-grants-2014_09
HRID 874079 반응식
HRID 874079반응물로uspto-grants-2015_03
HRID 874080 반응식
HRID 874080반응물로uspto-grants-2015_03

화합물 노트

불러오는 중…

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
더보기
새 노트새 반응견적 요청하기
Adverse EffectsACGIH Carcinogen - Not Classifiable.